Practice ("GMP") contract manufacturing capacity for lyophilisation
Discover sales predictions for the overall lyophilisation for pharmaceuticals market and the major Submarkets In addition to analyses of the overall world market, you will see revenue forecasting of four world-level submarkets to 2025: -- cGMP lyophilisers -- Laboratory lyophilisers -- Lyophilisation services -- Others
This will give you insight into the leading Lyophilisation Products and Services market and their growth potential over the forecast period.
8220;Our research shows that the world lyophilisation industry and market will benefit from the launch of new biologic drugs and vaccines.
Its research, data and analyses cover activities of GEA Lyophil, Labconco Corporation, Vetter Pharma-Fertigung, Piramal Pharma Solutions (PPS), SP Scientific and other providers of lyophilisation products and services to healthcare.
is a dehydration process for stabilising these valuable medical substances that is conducted in highly controlled environments and in compliance with strict regulatory guidelines.
In addition to analyses of the overall world market, you will see revenue forecasting of four world-level submarkets to 2024: -- cGMP lyophilisers -- Laboratory lyophilisers -- Lyophilisation
services -- Others
Our report discusses issues and events affecting that industry and market from 2013 onwards: -- Cell-based techniques - mammalian cell lines, avian-derived cells, plant-based processes and other methods -- Next-generation expression systems and vectors - increasing yields -- Recombinant DNA technologies -- Equipment, including single-use (disposable) bioreactors and prefilled syringes -- Product stability, lyophilisation
and quality assurance programmes.
A new report by visiongain predicts that the 2012 world market for lyophilisation
(freeze drying) products and services for pharma will reach $2.
A new report by visiongain, a London-based business information provider, predicts that the global lyophilisation
market will be worth $3.
biosimilars) and orphan drugs -- Development of antibody-drug conjugates (ADCs) -- Lyophilisation
, other drying technology, and aseptic filling -- Technologies to stimulate market expansion.
CEO's Perspective - Lyophilisation
and manufacturing of sterile products such as cytotoxics will likely be areas of growth potential, given the demand for oncology and high-potency drugs.